Replies to post #198031 on Biotech Values

[oldberkeley]

STML- Appreciate your reply and other PM replies. Going to hold, see what happens.

[oldberkeley]

STML: Just listened to Stemline CEO’s presentation at the Oppenheimer Healthcare Conference.

https://www.veracast.com/webcasts/opco/healthcare2015/25211513107.cfm

Data were same as on the ASH15 poster, but to a layperson like me, it seems impressive. The before and after photos of the BPDCN skin lesions and bone marrow biopsies are remarkable.

[bladerunner1717]

re: STML

If you listen to today's presentation at Oppenheimer, the CEO Bergstein addresses some of the toxicity concerns.

https://www.veracast.com/webcasts/opco/healthcare2015/25211513107.cfm?0.143472521889

Overall, I agree with "Oldberkeley's" assessment. Hard to believe that this stock is selling at virtually cash vale.

The resignation of CMO, Dr. Eric Rowinsky, is a bit of a red flag to me, but he is staying on as a "consultant" for two years, whatever that means.

Hammer seems on the fence about STML.

Bladerunner